SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001082554-23-000014
Filing Date
2023-05-03
Accepted
2023-05-03 06:06:36
Documents
14
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K uthr-20230503.htm   iXBRL 8-K 37510
2 EX-99.1 uthrq12023-ex991.htm EX-99.1 159402
6 GRAPHIC red_topper3a.gif GRAPHIC 143263
  Complete submission text file 0001082554-23-000014.txt   542923

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20230503.xsd EX-101.SCH 1937
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20230503_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20230503_pre.xml EX-101.PRE 12542
8 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20230503_htm.xml XML 10835
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 23881526
SIC: 2834 Pharmaceutical Preparations